Amitabh Bachchan's ICU Blog...

Amitabh Bachchan clarified that his viral ICU blog was a...

‘Miracle on the Hudson’...

Captain Chesley 'Sully' Sullenberger, renowned for the 'Miracle on the Hudson' landing, has...

Can Fluvoxamine, a Common...

A clinical trial found that Fluvoxamine reduced long COVID-related fatigue...

We’re A Top 30...

(image: Caleb Chen Unsplash) Thanks so much to Anuj at the team at...
HomeVIDEOSHow new Alzheimer's...

How new Alzheimer’s drug Leqembi works, risks and who might benefit



The FDA has approved a drug for people in the early stages of Alzheimer’s disease. CBS News’ chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit.

#news #alzheimer #health

Each weekday morning, “CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. “CBS Mornings” airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.

Subscribe to “CBS Mornings” on YouTube:
Watch CBS News:
Download the CBS News app:
Follow “CBS Mornings” on Instagram:
Like “CBS Mornings” on Facebook:
Follow “CBS Mornings” on Twitter:
Subscribe to our newsletter:
Try Paramount+ free:

For video licensing inquiries, contact: licensing@veritone.com

source

Continue reading

Amitabh Bachchan's ICU Blog Post Created a Buzz: What Was It Actually About?

Amitabh Bachchan clarified that his viral ICU blog was a metaphor for Argentina's World Cup defeat, highlighting recovery after critical illness and major setbacks.

‘Miracle on the Hudson’ pilot Sully Sullenberger reveals Alzheimer’s diagnosis #Shorts #WorldBrief

Captain Chesley 'Sully' Sullenberger, renowned for the 'Miracle on the Hudson' landing, has announced his diagnosis with Alzheimer's disease. 📖 Full story: 🌐 worldbrief.fusionwire.ai · Facebook: facebook.com/1114935101709196 #Shorts #News #WorldBrief #Health source

Can Fluvoxamine, a Common Antidepressant, Ease Long COVID Fatigue?

A clinical trial found that Fluvoxamine reduced long COVID-related fatigue and improved quality of life, offering new hope for people with persistent symptoms.